DT
Denali Therapeutics Inc
🇩🇪XFRA.4DNGermanyHealthcare
€18.13EURup +0.23 (+1.28%)OpenEnd of day3:58 PM
Price€18.13+0.23 (+1.28%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US24823R1059
- CUSIP
- Not reported
Company
- Employees
- 503
- Headquarters
- South San Francisco, United States
- CEO
- Dr. Ryan J. Watts Ph.D.
Market
- Shares outstanding
- 159.8M
- Market cap
- €2.9B
Key dates
- Next earnings
- Nov 5, 2026
Highlights
No high and low reported for today's session.
- Market cap
- €2.9B
- EPS LTM
- -$3.20calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $3.6M+100%up year on year
- Net income
- -$511.45M-6.77%down year on year
- Gross margin
- -2,889.84%
- Free cash flow
- -$437.46M-18.89%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.